Prolyl 4-hydroxylase subunit alpha-2 acts as a TRIM21 ubiquitination substrate to promote papillary thyroid cancer progression via the glycolytic pathway. This evidence concerns the gene TRIM21 and thyroid gland papillary carcinoma.